Literature DB >> 25518962

NH2-terminal truncations of cardiac troponin I and cardiac troponin T produce distinct effects on contractility and calcium homeostasis in adult cardiomyocytes.

Hongguang Wei1, J-P Jin2.   

Abstract

Cardiac troponin I (TnI) has an NH2-terminal extension that is an adult heart-specific regulatory structure. Restrictive proteolytic truncation of the NH2-terminal extension of cardiac TnI occurs in normal hearts and is upregulated in cardiac adaptation to hemodynamic stress or β-adrenergic deficiency. NH2-terminal truncated cardiac TnI (cTnI-ND) alters the conformation of the core structure of cardiac TnI similarly to that produced by PKA phosphorylation of Ser(23/24) in the NH2-terminal extension. At organ level, cTnI-ND enhances ventricular diastolic function. The NH2-terminal region of cardiac troponin T (TnT) is another regulatory structure that can be selectively cleaved via restrictive proteolysis. Structural variations in the NH2-terminal region of TnT also alter the molecular conformation and function. Transgenic mouse hearts expressing NH2-terminal truncated cardiac TnT (cTnT-ND) showed slower contractile velocity to prolong ventricular rapid-ejection time, resulting in higher stroke volume. Our present study compared the effects of cTnI-ND and cTnT-ND in cardiomyocytes isolated from transgenic mice on cellular morphology, contractility, and calcium kinetics. Resting cTnI-ND, but not cTnT-ND, cardiomyocytes had shorter length than wild-type cells with no change in sarcomere length. cTnI-ND, but not cTnT-ND, cardiomyocytes produced higher contractile amplitude and faster shortening and relengthening velocities in the absence of external load than wild-type controls. Although the baseline and peak levels of cytosolic Ca(2+) were not changed, Ca(2+) resequestration was faster in both cTnI-ND and cTnT-ND cardiomyocytes than in wild-type control. The distinct effects of cTnI-ND and cTnT-ND demonstrate their roles in selectively modulating diastolic or systolic functions of the heart.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cardiac troponin I; cardiac troponin T; contractility; intracellular calcium transient; isolated mouse adult cardiomyocyte

Mesh:

Substances:

Year:  2014        PMID: 25518962      PMCID: PMC4346733          DOI: 10.1152/ajpcell.00358.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  35 in total

1.  The highly conserved COOH terminus of troponin I forms a Ca2+-modulated allosteric domain in the troponin complex.

Authors:  J P Jin; F W Yang; Z B Yu; C I Ruse; M Bond; A Chen
Journal:  Biochemistry       Date:  2001-02-27       Impact factor: 3.162

Review 2.  Regulation of contraction in striated muscle.

Authors:  A M Gordon; E Homsher; M Regnier
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

Review 3.  Troponin I: inhibitor or facilitator.

Authors:  S V Perry
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

4.  A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity.

Authors:  Z B Yu; L F Zhang; J P Jin
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

Review 5.  Isoform diversity, regulation, and functional adaptation of troponin and calponin.

Authors:  Jian-Ping Jin; Zhiling Zhang; James A Bautista
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

6.  The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments.

Authors:  M Chandra; D E Montgomery; J J Kim; R J Solaro
Journal:  J Mol Cell Cardiol       Date:  1999-04       Impact factor: 5.000

7.  Conformational modulation of slow skeletal muscle troponin T by an NH(2)-terminal metal-binding extension.

Authors:  J P Jin; A Chen; O Ogut; Q Q Huang
Journal:  Am J Physiol Cell Physiol       Date:  2000-10       Impact factor: 4.249

8.  Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling.

Authors:  Han-Zhong Feng; Min Chen; Lee S Weinstein; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

9.  Isolation and characterization of cDNA clones encoding embryonic and adult isoforms of rat cardiac troponin T.

Authors:  J P Jin; J J Lin
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

Review 10.  Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction.

Authors:  Donald M Bers
Journal:  Annu Rev Physiol       Date:  2013-11-13       Impact factor: 19.318

View more
  5 in total

1.  Sarcomeric protein modification during adrenergic stress enhances cross-bridge kinetics and cardiac output.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Jiayang Li; Hyerin Kwak; Julian E Stelzer
Journal:  J Appl Physiol (1985)       Date:  2016-12-01

2.  Amino Acid Changes at Arginine 204 of Troponin I Result in Increased Calcium Sensitivity of Force Development.

Authors:  Susan Nguyen; Rylie Siu; Shannamar Dewey; Ziyou Cui; Aldrin V Gomes
Journal:  Front Physiol       Date:  2016-11-15       Impact factor: 4.566

Review 3.  Protein Structure-Function Relationship at Work: Learning from Myopathy Mutations of the Slow Skeletal Muscle Isoform of Troponin T.

Authors:  Anupom Mondal; J-P Jin
Journal:  Front Physiol       Date:  2016-10-13       Impact factor: 4.566

Review 4.  Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders.

Authors:  Christopher R Solaro; R John Solaro
Journal:  J Mol Cell Cardiol       Date:  2020-05-19       Impact factor: 5.000

5.  Intranuclear cardiac troponin I plays a functional role in regulating Atp2a2 expression in cardiomyocytes.

Authors:  Qian Lu; Bo Pan; Haobo Bai; Weian Zhao; Lingjuan Liu; Gu Li; Ruimin Liu; Tiewei Lv; Xupei Huang; Xi Li; Jie Tian
Journal:  Genes Dis       Date:  2021-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.